🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase II trial studies how well olaparib and ceralasertib (AZD6738) wo...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2020-01-30
Trial ID
NCT03878095
To assess the effect of AZD6738 and Durvalumab combination or AZD6738 and O...
Status
Unknown
Location
Seoul National University Hospital
Start Date
2020-06-25
Trial ID
NCT04298021
Treatments Being Tested
This biomarker study has been designed to assess the effects of different a...
Status
Completed
Location
Research Site
Start Date
2017-09-18
Trial ID
NCT03022409
Treatments Being Tested
ATARI trial tests the ATR inhibitor drug ceralasertib (AZD6738) alone and i...
Status
Active Not Recruiting
Location
The Ottawa Hospital Cancer Centre
Start Date
2019-11-27
Trial ID
NCT04065269
Treatments Being Tested
This phase II trial studies how well ceralasertib, am Ataxia telangiectasia...
Status
Active Not Recruiting
Location
City of Hope Comprehensive Cancer Center
Start Date
2019-01-17
Trial ID
NCT03682289
Treatments Being Tested
This phase II study assesses the efficacy of the combination of olaparib wi...
Status
Terminated
Location
OHSU Knight Cancer Institute
Start Date
2018-12-12
Trial ID
NCT03801369
Treatments Being Tested
The purpose of this study is to test the effectiveness (how well the drugs ...
Status
Active Not Recruiting
Location
University of Michigan Hospital
Start Date
2019-10-31
Trial ID
NCT03787680
This is an open-label, multi-centre, umbrella Phase II study in participant...
Status
Active Not Recruiting
Location
Research Site
Start Date
2017-12-18
Trial ID
NCT03334617
Treatments Being Tested
Investigational agent, AZD6738 will be given in combination with Olaparib t...
Status
Completed
Location
Johns Hopkins University School of Medicine
Start Date
2018-03-09
Trial ID
NCT03462342
Treatments Being Tested
plasmaMATCH is a multi-centre phase IIa umbrella trial platform consisting ...
Status
Unknown
Location
Royal Marsden Hosital
Start Date
2016-12-15
Trial ID
NCT03182634
Treatments Being Tested